Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial.

Kasting ML, Head KJ, Cox D, Cox AD, Zimet GD.

Prev Med. 2019 Aug 9:105798. doi: 10.1016/j.ypmed.2019.105798. [Epub ahead of print]

PMID:
31404569
2.

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

Blake DR, Vaseva AV, Hodge RG, Kline MP, Gilbert TSK, Tyagi V, Huang D, Whiten GC, Larson JE, Wang X, Pearce KH, Herring LE, Graves LM, Frye SV, Emanuele MJ, Cox AD, Der CJ.

Sci Signal. 2019 Jul 16;12(590). pii: eaav7259. doi: 10.1126/scisignal.aav7259.

PMID:
31311847
3.

Fatigue, Physical and Functional Mobility, and Obesity in Pediatric Cancer Survivors.

Karimi M, Cox AD, White SV, Karlson CW.

Cancer Nurs. 2019 Mar 29. doi: 10.1097/NCC.0000000000000712. [Epub ahead of print]

PMID:
30925511
4.

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, Diehl JN, Goode GD, Chaika NV, Wang Y, Zhang GF, Witkiewicz AK, Knudsen ES, Petricoin EF 3rd, Singh PK, Macdonald JM, Tran NL, Lyssiotis CA, Ying H, Kimmelman AC, Cox AD, Der CJ.

Nat Med. 2019 Apr;25(4):628-640. doi: 10.1038/s41591-019-0368-8. Epub 2019 Mar 4.

5.

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism.

Vaseva AV, Blake DR, Gilbert TSK, Ng S, Hostetter G, Azam SH, Ozkan-Dagliyan I, Gautam P, Bryant KL, Pearce KH, Herring LE, Han H, Graves LM, Witkiewicz AK, Knudsen ES, Pecot CV, Rashid N, Houghton PJ, Wennerberg K, Cox AD, Der CJ.

Cancer Cell. 2018 Nov 12;34(5):807-822.e7. doi: 10.1016/j.ccell.2018.10.001.

PMID:
30423298
6.

d-Glycero-β-d-Manno-Heptose 1-Phosphate and d-Glycero-β-d-Manno-Heptose 1,7-Biphosphate Are Both Innate Immune Agonists.

Adekoya IA, Guo CX, Gray-Owen SD, Cox AD, Sauvageau J.

J Immunol. 2018 Oct 15;201(8):2385-2391. doi: 10.4049/jimmunol.1801012. Epub 2018 Sep 17.

PMID:
30224513
7.
8.

Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.

Nix EB, Choi J, Anthes C, Gaultier GN, Thorgrimson J, Cox AD, Tsang RSW, McCready WG, Boreham D, Ulanova M.

PLoS One. 2018 Aug 15;13(8):e0201282. doi: 10.1371/journal.pone.0201282. eCollection 2018.

9.

A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.

Ram S, Gulati S, Lewis LA, Chakraborti S, Zheng B, DeOliveira RB, Reed GW, Cox AD, Li J, St Michael F, Stupak J, Su XH, Saha S, Landig CS, Varki A, Rice PA.

Infect Immun. 2018 Jul 23;86(8). pii: e00285-18. doi: 10.1128/IAI.00285-18. Print 2018 Aug.

10.

Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop.

Cox AD, Barreto L, Ulanova M, Bruce MG, Tsang R; Conference contributors.

Can Commun Dis Rep. 2017 May 4;43(5):89-95. eCollection 2017 May 4.

11.

The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action.

Barreto L, Cox AD, Ulanova M, Bruce MG, Tsang R.

Can Commun Dis Rep. 2017 May 4;43(5):85-88. eCollection 2017 May 4.

12.

Structure of the LPS O-chain from Fusobacterium nucleatum strain MJR 7757 B.

Vinogradov E, St Michael F, Cox AD.

Carbohydr Res. 2018 Jun 30;463:37-39. doi: 10.1016/j.carres.2018.04.010. Epub 2018 Apr 25.

PMID:
29753950
13.

Behavior and health beliefs as predictors of HIV testing among women: a prospective study of observed HIV testing.

Fan H, Fife KH, Cox D, Cox AD, Zimet GD.

AIDS Care. 2018 Aug;30(8):1062-1069. doi: 10.1080/09540121.2018.1442555. Epub 2018 Feb 22.

14.

Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans.

St Michael F, Yang Q, Cairns C, Vinogradov E, Fleming P, Hayes AC, Aubry A, Cox AD.

Glycoconj J. 2018 Feb;35(1):53-64. doi: 10.1007/s10719-017-9798-z. Epub 2017 Oct 2.

PMID:
28971282
15.

Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies.

Waters AM, Ozkan-Dagliyan I, Vaseva AV, Fer N, Strathern LA, Hobbs GA, Tessier-Cloutier B, Gillette WK, Bagni R, Whiteley GR, Hartley JL, McCormick F, Cox AD, Houghton PJ, Huntsman DG, Philips MR, Der CJ.

Sci Signal. 2017 Sep 26;10(498). pii: eaao3332. doi: 10.1126/scisignal.aao3332.

16.

Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.

Cox AD, Williams D, Cairns C, St Michael F, Fleming P, Vinogradov E, Arbour M, Masson L, Zou W.

Vaccine. 2017 Oct 27;35(45):6129-6136. doi: 10.1016/j.vaccine.2017.09.055. Epub 2017 Sep 23.

PMID:
28951087
17.

Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in Pasteurella multocida and Their Role in Resistance to Cathelicidin-2.

Harper M, Wright A, St Michael F, Li J, Deveson Lucas D, Ford M, Adler B, Cox AD, Boyce JD.

Infect Immun. 2017 Oct 18;85(11). pii: e00557-17. doi: 10.1128/IAI.00557-17. Print 2017 Nov.

18.

First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development.

Salman M, St Michael F, Ali A, Jabbar A, Cairns C, Hayes AC, Rahman M, Iqbal M, Haque A, Cox AD.

J Immunol Methods. 2017 Nov;450:27-33. doi: 10.1016/j.jim.2017.07.005. Epub 2017 Jul 21.

PMID:
28735760
19.

Structure of the LPS O-chain from Fusobacterium nucleatum strain 12230.

Vinogradov E, St Michael F, Cox AD.

Carbohydr Res. 2017 Aug 7;448:115-117. doi: 10.1016/j.carres.2017.06.007. Epub 2017 Jun 16.

PMID:
28651243
20.

Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acid.

Vinogradov E, St Michael F, Homma K, Sharma A, Cox AD.

Carbohydr Res. 2017 Feb 22;440-441:38-42. doi: 10.1016/j.carres.2017.01.009. Epub 2017 Jan 28.

21.
22.

Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.

Justilien V, Ali SA, Jamieson L, Yin N, Cox AD, Der CJ, Murray NR, Fields AP.

Cancer Cell. 2017 Feb 13;31(2):256-269. doi: 10.1016/j.ccell.2016.12.010. Epub 2017 Jan 19.

23.

Does perceived risk influence the effects of message framing? Revisiting the link between prospect theory and message framing.

Van 't Riet J, Cox AD, Cox D, Zimet GD, De Bruijn GJ, Van den Putte B, De Vries H, Werrij MQ, Ruiter RA.

Health Psychol Rev. 2016 Dec;10(4):447-459. Epub 2016 Apr 27.

PMID:
27062974
24.

Establishing motion control in children with autism and intellectual disability: Applications for anatomical and functional MRI.

Cox AD, Virues-Ortega J, Julio F, Martin TL.

J Appl Behav Anal. 2017 Jan;50(1):8-26. doi: 10.1002/jaba.351. Epub 2016 Oct 14.

PMID:
27739580
25.

INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.

Zhang S, Zhou B, Wang L, Li P, Bennett BD, Snyder R, Garantziotis S, Fargo DC, Cox AD, Chen L, Hu G.

Oncogene. 2017 Mar;36(10):1430-1439. doi: 10.1038/onc.2016.311. Epub 2016 Sep 19.

26.

The role of wild type RAS isoforms in cancer.

Zhou B, Der CJ, Cox AD.

Semin Cell Dev Biol. 2016 Oct;58:60-9. doi: 10.1016/j.semcdb.2016.07.012. Epub 2016 Jul 13. Review.

27.

ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.

Ryan MB, Finn AJ, Pedone KH, Thomas NE, Der CJ, Cox AD.

Mol Cancer Res. 2016 Oct;14(10):1009-1018. Epub 2016 Jul 14.

28.

RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.

Meng X, Tackmann NR, Liu S, Yang J, Dong J, Wu C, Cox AD, Zhang Y.

Cancer Res. 2016 Sep 1;76(17):5030-9. doi: 10.1158/0008-5472.CAN-15-3420. Epub 2016 Jul 11.

29.

INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma.

Zhou B, Wang L, Zhang S, Bennett BD, He F, Zhang Y, Xiong C, Han L, Diao L, Li P, Fargo DC, Cox AD, Hu G.

Genes Dev. 2016 Jun 15;30(12):1440-53. doi: 10.1101/gad.277178.115.

30.
31.

Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.

Chakraborti S, Lewis LA, Cox AD, St Michael F, Li J, Rice PA, Ram S.

J Immunol. 2016 Jun 1;196(11):4576-86. doi: 10.4049/jimmunol.1600374. Epub 2016 May 2.

32.

Targeting RAS-mutant cancers: is ERK the key?

Ryan MB, Der CJ, Wang-Gillam A, Cox AD.

Trends Cancer. 2015 Nov 1;1(3):183-198.

33.

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.

Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, Aziz M, Kassner M, Bryant KL, Pierobon M, Marayati R, Kher S, George SD, Xu M, Wang-Gillam A, Samatar AA, Maitra A, Wennerberg K, Petricoin EF 3rd, Yin HH, Nelkin B, Cox AD, Yeh JJ, Der CJ.

Cancer Cell. 2016 Jan 11;29(1):75-89. doi: 10.1016/j.ccell.2015.11.011. Epub 2015 Dec 24.

34.

Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.

Gulati S, Schoenhofen IC, Whitfield DM, Cox AD, Li J, St Michael F, Vinogradov EV, Stupak J, Zheng B, Ohnishi M, Unemo M, Lewis LA, Taylor RE, Landig CS, Diaz S, Reed GW, Varki A, Rice PA, Ram S.

PLoS Pathog. 2015 Dec 2;11(12):e1005290. doi: 10.1371/journal.ppat.1005290. eCollection 2015 Dec.

35.

Interactions between behavior function and psychotropic medication.

Cox AD, Virues-Ortega J.

J Appl Behav Anal. 2016 Mar;49(1):85-104. doi: 10.1002/jaba.247. Epub 2015 Sep 22. Review.

PMID:
26391410
36.

Up-front polytherapy for ALK-positive lung cancer.

Zhou B, Cox AD.

Nat Med. 2015 Sep;21(9):974-5. doi: 10.1038/nm.3942. No abstract available.

PMID:
26340116
37.

Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.

Gentry LR, Nishimura A, Cox AD, Martin TD, Tsygankov D, Nishida M, Elston TC, Der CJ.

J Biol Chem. 2015 Sep 11;290(37):22851-61. doi: 10.1074/jbc.M115.656710. Epub 2015 Jul 27.

38.

The C. elegans Chp/Wrch Ortholog CHW-1 Contributes to LIN-18/Ryk and LIN-17/Frizzled Signaling in Cell Polarity.

Kidd AR 3rd, Muñiz-Medina V, Der CJ, Cox AD, Reiner DJ.

PLoS One. 2015 Jul 24;10(7):e0133226. doi: 10.1371/journal.pone.0133226. eCollection 2015.

39.

INNATE IMMUNITY. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity.

Gaudet RG, Sintsova A, Buckwalter CM, Leung N, Cochrane A, Li J, Cox AD, Moffat J, Gray-Owen SD.

Science. 2015 Jun 12;348(6240):1251-5. doi: 10.1126/science.aaa4921.

40.

Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Cox AD, Der CJ, Philips MR.

Clin Cancer Res. 2015 Apr 15;21(8):1819-27. doi: 10.1158/1078-0432.CCR-14-3214. Review.

41.

Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors.

Wang EC, Min Y, Palm RC, Fiordalisi JJ, Wagner KT, Hyder N, Cox AD, Caster JM, Tian X, Wang AZ.

Biomaterials. 2015 May;51:208-215. doi: 10.1016/j.biomaterials.2015.02.015. Epub 2015 Feb 19.

42.

Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.

Choi J, Nix EB, Gaultier GN, Cox AD, McCready W, Ulanova M.

Vaccine. 2015 Apr 15;33(16):1941-7. doi: 10.1016/j.vaccine.2015.02.060. Epub 2015 Mar 1.

PMID:
25738817
43.

Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M.

Emerg Infect Dis. 2015 Feb;21(2):273-9. doi: 10.3201/eid2102.140722.

44.

Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis.

Reinhardt A, Yang Y, Claus H, Pereira CL, Cox AD, Vogel U, Anish C, Seeberger PH.

Chem Biol. 2015 Jan 22;22(1):38-49. doi: 10.1016/j.chembiol.2014.11.016. Epub 2015 Jan 15.

45.

Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies.

Perry JE, Cox D, Cox AD.

J Law Med Ethics. 2014 Winter;42(4):475-91. doi: 10.1111/jlme.12169.

PMID:
25565614
46.

K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.

Tsai FD, Lopes MS, Zhou M, Court H, Ponce O, Fiordalisi JJ, Gierut JJ, Cox AD, Haigis KM, Philips MR.

Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):779-84. doi: 10.1073/pnas.1412811112. Epub 2015 Jan 5.

47.

Development of a rapid multiplex PCR assay to genotype Pasteurella multocida strains by use of the lipopolysaccharide outer core biosynthesis locus.

Harper M, John M, Turni C, Edmunds M, St Michael F, Adler B, Blackall PJ, Cox AD, Boyce JD.

J Clin Microbiol. 2015 Feb;53(2):477-85. doi: 10.1128/JCM.02824-14. Epub 2014 Nov 26.

48.

The influence of staff training on challenging behaviour in individuals with intellectual disability: a review.

Cox AD, Dube C, Temple B.

J Intellect Disabil. 2015 Mar;19(1):69-82. doi: 10.1177/1744629514558075. Epub 2014 Nov 12. Review.

PMID:
25395332
49.

The effects of HIV testing advocacy messages on test acceptance: a randomized clinical trial.

Kasting ML, Cox AD, Cox D, Fife KH, Katz BP, Zimet GD.

BMC Med. 2014 Nov 6;12:204. doi: 10.1186/s12916-014-0204-4.

50.

Drugging the undruggable RAS: Mission possible?

Cox AD, Fesik SW, Kimmelman AC, Luo J, Der CJ.

Nat Rev Drug Discov. 2014 Nov;13(11):828-51. doi: 10.1038/nrd4389. Epub 2014 Oct 17. Review.

Supplemental Content

Support Center